In a remarkable medical breakthrough, a 62-year-old man from Toronto is on the verge of being declared cured of HIV following a bone marrow transplant aimed at treating his acute myelogenous leukemia. Identified only as the “Toronto patient” by health officials, his case, which showcases the potential of innovative treatments, was presented at the Canadian Association of HIV Research Conference in Winnipeg.
The Medical Journey
The Toronto patient received a bone marrow transplant at the Princess Margaret Cancer Centre, part of the University Health Network, in a procedure that has sparked hope for many living with HIV. Initially diagnosed with HIV in 1999, he had been managing the virus with antiretroviral therapy for nearly three decades. However, in July 2025, he ceased his medication, and by April 2026, his HIV levels had become undetectable, leading health professionals to believe he may have achieved a sustained remission.
The transplant involved donor stem cells that carried a rare genetic mutation known as “delta-32,” which affects the CCR5 gene responsible for HIV’s entry into immune cells. According to Mario Ostrowski, a clinician-scientist at St. Michael’s Hospital, only about one per cent of individuals of European descent possess this mutation, making them naturally resistant to HIV. “A bone marrow transplant from these donors can provide a potential cure,” Ostrowski noted.
The Search for a Match
Finding a compatible donor was no small feat. Dr. Jonas Mattson, who worked with the patient, explained that doctors initially sought a familial match but, upon failing to find one, expanded their search globally. Doctors accessed databases containing over 47 million potential donors across the German and U.S. registries, significantly broadening the scope for finding a suitable match. “The idea is to find as good a match as possible because that will increase the chances that the transplant will be successful,” Mattson stated.
Ultimately, three donors with the desired genetic mutation were located. The transplant replaced the patient’s compromised immune system with a new, healthy one, which also turned out to be resistant to HIV. “The patient’s old immune system was completely gone and replaced by this new immune system, and the cancer was gone,” Mattson confirmed.
Caution in Optimism
Despite the exciting results, experts urge caution. Dr. Tommy Alfaro Moya, also from the Princess Margaret Cancer Centre, emphasised that this case should not be viewed as a standard treatment for HIV. “This was a very wonderful, extraordinary outcome of the transplant, but it was not the primary outcome why this individual got a transplant,” he clarified.
Dr. Sharon Walmsley, director of the HIV clinic at UHN, echoed this sentiment while highlighting the significance of the case. “This person now has an immune system that cannot be affected by HIV,” she said. “When we told him that we believe him to be cured, he was pretty astounded,” Walmsley added, indicating the profound impact this news has had on the patient’s life.
The Importance of Donor Registries
While the focus of the treatment was to address the patient’s cancer, the implications for HIV research are considerable. Walmsley stressed the necessity of donor registration, as these cases can lead to further breakthroughs in HIV treatments. “It’s really important that we have donors and we have registries so that we’re able to identify the specific bone marrows that we need when patients like these come around,” she noted.
The rarity of the delta-32 mutation illustrates the challenges faced in finding suitable matches for those in need, underscoring the importance of expanding donor registries to facilitate future medical advancements.
Why it Matters
This case not only highlights a significant scientific achievement but also serves as a beacon of hope for those living with HIV. The potential for a cure, while still in its infancy, opens doors to new avenues of research and treatment possibilities that could change the landscape of HIV care. As we continue to learn from such extraordinary outcomes, the advocacy for donor registration becomes paramount, reinforcing the collective responsibility to support medical research and provide hope to countless individuals affected by HIV.
